Table 5.
Number (%) of incident cases of malignancies in sex hormone dependent organs by age in the Swedish Prescribed Drugs and Health Cohort until 31st December 2015
| Sites | Total | Age, years | ||||
| <50 | 50–59 | 60–69 | 70–79 | 80+ | ||
| Breast | 86 405 (100.0) | 15 620 (18.1) | 16 858 (19.5) | 25 318 (29.3) | 16 349 (18.9) | 12 260 (14.2) |
| Breast (only females) | 85 965 (100.0) | 15 581 (18.1) | 16 792 (19.5) | 25 200 (29.3) | 16 233 (18.9) | 12 159 (14.1) |
| Cervix uteri | 66 212 (100.0) | 60 212 (90.9) | 3265 (4.9) | 1413 (2.1) | 790 (1.2) | 593 (0.9) |
| Corpus uteri | 15 342 (100.0) | 1131 (7.4) | 2436 (15.9) | 4563 (29.7) | 4286 (27.9) | 2926 (19.1) |
| Ovary | 10 263 (100.0) | 2348 (22.9) | 2024 (19.7) | 2791 (27.2) | 1976 (19.3) | 1124 (11.0) |
| Prostate | 101 724 (100.0) | 929 (0.9) | 11 939 (11.7) | 41 092 (40.4) | 32 406 (31.9) | 15 358 (15.1) |
| Testis | 3278 (100.0) | 2832 (86.4) | 260 (7.9) | 100 (3.1) | 63 (1.9) | 23 (0.7) |